Risk Factors

424 articles

Member
September 15, 2022 • 2 Min

Gil Bashe

Our health system is hard to navigate — sometimes the sectors seem at odds. But, patients expect that each piece of the medical puzzle – physician, provider, payer, pharma and policy – will focus on their wellbeing. Through my 30+ years in health, I’ve believed that communication with the patient is a crucial part of […]

Survivor Stories
March 21, 2019 • 5 Min

Long-Term Survival After Grueling Radiation Treatment

Long-term pancreatic cancer survivor Steven Yedwabnick endured a long protocol of radiation and chemotherapy after a Whipple surgery.

Research
August 18, 2016 • 2 Min

Exploring the Effectiveness of an Experimental Class of Drug

Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?

Research
October 18, 2016 • 2 Min

A New Drug Combination to Control Advanced Pancreatic Cancer

A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.

Survivor Stories
July 29, 2019 • 4 Min

Surviving Pancreatic Cancer and Embracing Life

Joel Evans’ endocrinologist was concerned so he sent him to get tested for pancreatic cancer. It was caught early enough for a Whipple procedure.

Survivor Stories
December 18, 2019 • 6 Min

Blessed to Be Here and Healthy

Jacqueline Sims-Mayes is blessed to be a pancreatic cancer survivor. Her faith helped her through a difficult recovery from Whipple surgery.

Research
February 7, 2019 • 2 Min

Testing a Different Approach to Pancreatic Cancer Treatment

A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.

Research
July 31, 2020 • 3 Min

Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer

This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.

Research
November 6, 2020 • 2 Min

An Expanded Access Trial for Cancer Patients with Specific Mutations

An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.

Survivor Stories
February 4, 2021 • 7 Min

My Most Challenging Race

Eric Lasner faced Whipple surgery, chemotherapy with FOLFIRINOX, and radiation, in order to get back to closed circuit road racing.

Survivor Stories
February 17, 2021 • 3 Min

Time and Hope

Rose farmer Michael Francis wanted more time with his family, so he joined a clinical trial to treat his stage III pancreatic cancer.

Survivor Stories
August 30, 2022 • 3 Min

Family History Matters

After Martin Abrams lost two siblings to pancreatic cancer, he made sure he was screened regularly because of his family history.

Survivor Stories
August 17, 2022 • 6 Min

Going Outside Standard Protocol Changed Everything

Sharon Rockmaker was determined to have a Whipple procedure despite having stage IV pancreatic cancer, and she finally did.

Research
June 17, 2022 • 3 Min

New Gene Inhibitor Drug for Patients with MTAP-Deleted Tumors

A new trial targets patients with advanced solid tumors, including pancreatic cancer, with an MTAP-deletion genetic mutation.

Survivor Stories
March 16, 2022 • 4 Min

Pancreatitis and Pancreatic Cancer

When Wayne was diagnosed with pancreatitis, the tests showed a very high likelihood of pancreatic cancer.